Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find out if giving azacitidine with valproic
acid plus carboplatin can help control advanced cancer. The safety of this treatment will be
studied as well. Researchers will also collect some extra blood samples for molecular marker
studies (studies that may help researchers predict how participants respond to the combined
therapy).
There were to be two phases of this study: a Phase 1 portion to find acceptable doses of the
study drug combination, and a Phase 2 portion to study the response rates to the treatment
schedule. The study did not proceed to the Phase 2 portion.